{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lake Forest",
      "state": "IL",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "72192",
      "recalling_firm": "Akorn, Inc.",
      "address_1": "1925 W. Field Court, Suite 300",
      "address_2": "N/A",
      "postal_code": "60045",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "US: Nationwide",
      "recall_number": "D-0231-2016",
      "product_description": "RIFAMPIN FOR INJECTION USP, 600 mg*/vial, Rx Only. Mfd. for: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-151-42.",
      "product_quantity": "6861 Vials",
      "reason_for_recall": "Failed Impurity/Degradation Specifications:  Out of Specifications result obtained for a known impurity.",
      "recall_initiation_date": "20150820",
      "center_classification_date": "20151113",
      "termination_date": "20170126",
      "report_date": "20151125",
      "code_info": "Lot #: 14RIF1(A), Expiry: 9/30/2016."
    }
  ]
}